This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Ocular Hypertension
+1

Ocular Hypertension Treatment Study (OHTS)

Sponsored by The New York Eye & Ear Infirmary

About this trial

Last updated 12 years ago

Study ID

93.01

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
40 to 80 Years
All
All

Trial Timing

Ended 19 years ago

What is this trial about?

The Ocular Hypertension Treatment Study is a multi-center clinical trial sponsored by the National Eye Institute, designed to determine the efficacy and safety of topically administered eye lowering medication

What are the participation requirements?

Yes

Inclusion Criteria

- Qualifying IOP in at least one eye of each participant must be more than or equal 24 mmHg but less than or equal to 32 mm HG calculated from two separate consecutive determination taken at least 2 hours, but not greater than 12 weeks apart.

- Normal and reliable 30-2 Humphrey Visual Fields in both eyes.

- Normal Optic disc in both eyes on clinical examinations and stereoscopic photographs as determined by the Optic Disc Reading Center.

No

Exclusion Criteria

- Visual acuity worse than 20/40 in either eye on qualifying exam.

- Previous intraocular surgery: laser trabeculoplasty, laser iridotomy, filtering surgery, combined cataract extraction/filtering procedures, penetrating keratoplasty and retinal detachment repair.